identified as a circulating age-associated factor that increased with age in rats and humans. 11 In the past, GDF11 has been proposed to restore skeletal muscle functions and increase bone formation by inhibiting the activity of PPAR-γ. 12 ,13 but a recent study showed that GDF11 had negative effect on muscle and bone regeneration. 14, 15 This difference in function of GDF11 maybe due to the reagents previously used to detect GDF11 not being GDF11 specific. 14 Vitamin D has an important effect on bone metabolism and is formed in the epidermis or provided by the diet. 16 A positive association has been proved between vitamin D status and BMD in previous studies. 17 The present study was undertaken to elucidate the relationship of serum GDF8, GDF11 levels with BMD in adolescent girls with AN.
| MATERIAL AND ME THODS

| Subjects
We enrolled 25 adolescent girls meeting DSM-5 (Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition) criteria 18 for AN and 31 healthy girls. Girls with AN did not differ from controls for chronological age (14.6 ± 1.3 vs 14.0 ± 1.1 years). Duration since diagnosis ranged from 3 to 20 months. Subjects had not taken any special medicines which led to weight loss or influenced indicators.
All of the AN girls had amenorrhoea. AN girls were referred by eating disorder providers in the Changsha (China) and its surrounding area, and healthy controls recruited through mailings to paediatricians.
All subjects were screened through a detailed questionnaire, medical history and physical examination. Information on dietary intake through a food frequency questionnaire, as well as habitual physical activity, was recorded. Body height and weight were measured using a stadiometer and a standardized balance beam scale, respectively.
This study was approval by the Xiangya Hospital of Central
South University Research Ethics Committee, and all girls and their parents gave their informed consent to participate.
| Serum GDF8 and GDF11 measurements
Blood samples were collected between 7:00 am and 9:00 am after fasting overnight and allowed to clot. Thereafter, the samples were centrifuged and divided into aliquots and stored at −80°C until assayed.
Serum GDF8 was measured by a sensitive enzyme-linked immunosorbent assay (ELISA) kit (DGDF80; R&D Systems, Minneapolis, MN, USA) based on a monoclonal antibody specific for mature GDF8. There is no cross-reactivity to GDF11 or myoglobin. The coefficient of the variation was lower than 10% for GDF8.
To minimize potential cross-reactivity with GDF8, we measured serum GDF11 concentration with a sensitive ELISA kit according to 
| Bone mineral density (BMD) measurements
Bone mineral density was measured by dual energy X-ray absorptiometry (DXA) using a Lunar device (Lunar DPX IQ, WI, MA, USA) as previously described. 19, 20 Included were the lumbar spine (L1-L4), the femoral neck of left hip and total body. All BMD results were expressed in g/cm 2 . Body fat mass and lean mass were measured using DXA.
The precision of the DXA was evaluated over three repeated measurements of different BMD values in 22 subjects and gave a mean coefficient of variation (CV) for all regions of 0.75 ± 0.21% (mean ± SD; range: 0.47-1.02%). A control spine phantom scan was performed everyday with a long-term (more than 10 years) CV of 0.31%-0.43% and the root-mean-square coefficient of variation was 0.35%.
| Hormone assays
Serum oestradiol level was determined with a competitive im- 
| Statistical analysis
| RE SULTS
| Characteristics of the subjects
Twenty-five girls (12-16 years old) with AN and 31 healthy girls (12-16 years old) were studied. The characteristics of the subjects are summarized in Table 1 . GDF8 levels were lower in girls with AN compared to the control group (3.13 ± 1.10 vs 4.23 ± 1.22, P = 0.001). On the contrary, GDF11 levels were higher in girls with AN than that of the healthy group (2.92 ± 0.78 vs 2.28 ± 0.85, P = 0.005). Table 2 shows that there were significant negative correlations between GDF11 and BMD at lumbar spine, total body and femoral neck, which remained significant after adjustment for BMI and lean mass. There was no relationship between GDF8 and BMD at lumbar spine, total body and femoral neck.
| Relationship between levels of GDF8, GDF11 and BMD
| Multiple regression analysis identified as predictors of BMD
Regression modelling to eliminate confounding variables was performed for the group as a whole and also for the individual groups.
The parameters identified as significant and independent determinant factors of BMD for the group as a whole by multiple linear regression analysis are shown in Table 3 . The dependent variables were BMD at lumbar spine, femoral neck and total body. Several independent variables were entered in the regression analysis models, including age, BMI, fat mass, lean mass, 25-hydroxyvitamin D, oestradiol, GDF8 and GDF11. In the model with BMD at lumbar spine as the dependent variable, the significant independent variables were BMI, GDF11, lean mass and 25-hydroxyvitamin D, and these explained 84.3% of BMD at lumbar spine variance (R 2 = 0.843).
In the model with femoral neck BMD as the dependent variable, the significant independent variables were BMI, GDF11, lean mass and In the model with femoral neck BMD as the dependent variable, the significant independent variables were BMI, GDF11 and 25-hydroxyvitamin D, and these explained 82.8% of femoral neck BMD variance (R 2 = 0.828). In the model with total body BMD as the dependent variable, the significant independent variables were BMI, GDF11 and 25-hydroxyvitamin D, and these explained 83.5% of total body BMD variance (R 2 = 0.835). The results are shown in Table 4 .
In the control group, BMI, GDF11, lean mass or 25-hydroxyvitamin D were significant and independent determinant factors. In the model with BMD at lumbar spine as the dependent variable, the significant independent variables were BMI, GDF11 and lean mass, and these explained 76.5% of BMD at lumbar spine variance (R 2 = 0.765). In the model with femoral neck BMD as the dependent variable, the significant independent variables were BMI, GDF11, lean mass and 25-hydroxyvitamin D, and these explained 80.4% of femoral neck BMD variance (R 2 = 0.804). In the model with total body BMD as the dependent variable, the significant independent variables were BMI, GDF11 and lean mass, and these explained 75.8% of total body BMD variance (R 2 = 0.758). The results are shown in Table 5 .
| D ISCUSS I ON
Anorexia nervosa patients are always characterized with a low body weight. Studies have shown that AN is associated with multiple medical co-morbidities including significant and often permanent bone loss. It is well known that loss of muscle mass is associated with loss of BMD. 21 The precise mechanisms responsible for synchronizing bone and skeletal mass are still unclear.
Circulating cytokines may play important roles. Recent studies have shown that GDF8 negatively regulates muscle and bone regeneration 8, 22 and GDF11 is indicated to be an inhibitor of skeletal muscle regeneration and bone formation. 7, 14, 23 Many researchers have studied the relationship between AN and BMD, GDF8, GDF11 and BMD, 24 but this is the first report to investigate the relationship in young girls.
There is accumulating evidence that the reduction in muscle mass, strength and function is always associated with osteoporosis. 25 GDF8
can indirectly suppress bone formation and remodelling by inhibiting muscle growth. In mice, intraperitoneal injection of recombinant GDF8 repressed bone formation and accelerated bone resorption 26 .
While the mice with myostatin null have increased osteoblast activity and increased bone mass, 27, 28 our results showed that GDF8 levels decreased in girls with AN compared to the control group. While no relationship between GDF8 and BMD, it seemed a little positive correlation between the two factors, but without statistical significance, different from the previous study. Low level may explain it. In a study, the researcher found after injection of recombinant myostatin propeptide-Fc, the muscle mass increased, but revealed no differences of bone density, so they thought myostatin had a more pronounced effect on skeletal muscle than on bone. It provided a new possibility TA B L E 3 Parameters identified as significant and independent predictors of bone mineral density (BMD) in the group as a whole (n = 56) 34 so the decline of GDF8 may make it possible for GDF11 to function better. Compared with healthy group, the level of GDF11 increased in girls with AN, it is believed to partially depress bone growth, GDF11 may influence bone metabolism stronger, this assumption was confirmed in the further study. BMI and lean mass are determining factors of bone status in anorexia nervosa. 35, 36 In this study, we found GDF11 correlated negatively with BMD at lumbar spine, total hip and femoral neck in girls with AN; this association was independent of BMI and lean mass. Moreover, significant predictors for BMD at various skeletal regions in the group as a whole and also in the individual groups, as assessed by multiple linear regression analysis, were lean mass ，25-hydroxyvitamin D, BMI and GDF11, but not GDF8 and fat mass. It suggested that GDF11 was an independent negative predictor of BMD in the AN group. BMD was determined by lean mass and 25-hydroxyvitamin D. Li et al 37 generated transgenic mice with skeleton-specific overexpression of GDF11 propeptide cDNA, which antagonized GDF11 activity in osteoblasts. These transgenic mice had increased osteoblast activity and enhanced bone formation. Li et al 37 on bone mass of AN be convincing.
In conclusion, the present study has provided evidence that GDF11 but not GDF8 was an independent negative predictor of BMD in girls with AN. A study proved that GDF11 repressed Runx2 expression by inducing SMAD2/3 phosphorylation during osteoblast differentiation to inhibit bone formation. 31 Another study discovered GDF11 not only inhibits osteoblast differentiation but also stimulates RANKL-induced osteoclastogenesis. 15 Our results might be explained by these mechanisms, but need further research to clarify. Our study provides the possibility of developing new medicines to reverse bone loss and thus possibly reducing fracture incidence in AN girls.
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